drugset / Trial / NCT03914404

Efficacy of γ-linolenic Acid and Thioctic Acid in Patients With Diabetic Neuropathy

NCT03914404

Phase 4 Completed 100 enrolled Chonbuk National University Hospital
RandomizedParallel-groupDouble-blindPrevention

Summary

This study was a 12-week, multi-center, randomized, double-blind, double dummy, parallel clinical trial to compare the efficacy of γ-linolenic acid and Thioctic acid in patients with diabetic neuropathy.

Timeline

Start
2016-01-26
Primary completion
2016-03-30
Completion
2018-07-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Thioctic Acid Unknown 600 mg
Subject γ-linoleic acid Unknown